A Case of T-cell Lymphoma on Face in Kidney Transplanted Patient.
- Author:
Hwan Jun CHOI
1
;
Sang Gue KANG
;
Jang Hyun LEE
;
Mi Sun KIM
Author Information
1. Department of Plastic and Reconstructive Surgery, College of Medicine, Soon Chun Hyang University, Seoul, Korea. medi619@hanmail.net
- Publication Type:Original Article
- Keywords:
Cyclosporin A;
T-cell lymphoma
- MeSH:
Allografts;
Bone Marrow Transplantation;
Cyclosporine;
Forehead;
Humans;
Immunosuppressive Agents;
Incidence;
Kidney Transplantation;
Kidney*;
Lymphoma, T-Cell*;
Male;
Recurrence;
Survival Rate;
T-Lymphocytes*
- From:Journal of the Korean Society of Plastic and Reconstructive Surgeons
2003;30(6):823-826
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Survival rate after renal transplantation has increased by using intense immunosuppressive agents and sophisticated operative techniques were introduced but incidences of malignancy is increasing after transplantation. Renal transplanted patients undergo variable malignancy but the acute T-cell lymphoma originating in the face is relative rare. Cyclosporin A is an immunosuppressive agent with selective inhibitory effects on T lymphocytes. It is currently available to use in organ and bone marrow transplantation recipients. We report a case of acute arising T-cell lymphoma on forehead of a 56-years-old male patient. This patient received renal allograft about 15 years ago. And then for recent 3 years, he takes Cyclosporin A 15mg/day due to allograft rejection. Its pathologic finding was diffuse large T-cell type and exhibited homogenecity of the tumor. He has been followed 3 months and no relapse occurred. We report this case with a brief review of literatures.
